This announcement is a separate document:
共同药业：1 发行人及保荐机构关于审核问询函的回复（豁免版修订稿）（2022年半年度财务数据更新）
Mutual Pharmaceuticals: 1 Responses from issuers and sponsors to the review enquiry letter (revised version of the exempted version) (Financial data update for the half year 2022)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.